Second, given that cancer-specific memory CD8+ T cells represent a primary target for cancer immunotherapy and that CD4+ T cells play a critical “helper” role in the execution of CD8+ responses, it is of great importance to identify T cell subset–specific differences in PD-1 signaling and its related molecular pathways. The gene discussed is CD8A; the disease is cancer.